Yeaman Kevin J's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Nov 24, 2023
- Accession no.
- 0001209191-23-056594
- Filed
- Nov 24, 2023
- Trade date
- Nov 21, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.83M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 | Class A Common Stock | MOption exerciseAcquired | +45,150 | $42.98 | +$1,940,547 | 97,029 | Indirect | |
| Nov 21, 2023 | Class A Common Stock | SSaleDisposed | −9,030 | $83.98F1 | −$758,339.4 | 87,999 | Indirect | |
| Nov 21, 2023 | Class A Common Stock | SSaleDisposed | −36,120 | $85.00 | −$3,070,200 | 51,879 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 | Class A Common Stock | MOption exerciseDisposed | −45,150 | $0.00 | $0 | 18,306 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple transactions at prices ranging from $83.45 to $84.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2022 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.